Donald Trump Is Giving Psychedelic Medicines a Welcome Boost
President Donald Trump signed an executive order on April 18, 2026, after a text from podcaster Joe Rogan highlighted ibogaine’s potential for opioid addiction. The order directs the FDA to issue priority review vouchers for selected psychedelic drugs and earmarks new federal funding for research. Market reaction was immediate, with shares of companies developing psychedelics jumping sharply. The move signals a dramatic shift in federal support for a field long confined to academic and niche clinics.
Mile Bluff Medical Center Says Security Incident that Involved Data Encryption Disrupted Phone, Computer Systems
Mile Bluff Medical Center in Mauston, Wisconsin, reported a security incident that encrypted data and disrupted phone and computer systems. Clinical teams immediately shifted to downtime procedures to keep patient care flowing while the hospital activated its security protocols. An...
Endpoints Wins Neal Awards for Trump and Gene Editing Coverage, JPM Event
Endpoints News earned three 2026 Neal Awards, honoring its in‑depth reporting on the pharmaceutical sector’s ties to the Trump administration, a three‑part series on gene‑editing breakthroughs, and its coverage of the JPMorgan health‑care conference. The awards, presented by the American...
New Primary Care Firm Mangrove Health Launches with Investment by Mako
Mangrove Health, a new primary‑care operator, was launched by seasoned healthcare leaders Elena Castañeda and Dr. Emily Maxson. The startup secured an investment from venture firm Mako, signaling confidence in its model. Mangrove aims to deliver integrated, technology‑enabled primary‑care services...
Insured Americans Face Significant Hurdles to Mental Health Services
The Mental Health Parity Index reveals that the nation’s four largest commercial insurers provide significantly fewer in‑network mental‑health and substance‑use disorder providers than physical‑health clinicians, with gaps ranging from 24% to 83%. Clinician reimbursement for behavioral health services is 16%‑59%...
HHS, Industry Leaders Spar over Drug Pricing, TrumpRx and PBMs
At a Politico‑hosted summit, U.S. health officials and pharma leaders clashed over the most‑favored‑nation (MFN) drug‑pricing policy championed by the Trump administration. The MFN proposal would force manufacturers to price drugs in the United States at levels comparable to lower‑cost...
Unnamed Pharma Files Citizen Petition Targeting FDA’s Trove of Rejection Letters
An unnamed pharmaceutical firm has lodged a citizen petition urging the FDA to halt its new practice of automatically publishing complete response letters (CRLs). The petition seeks a 10‑day notice period for sponsors to contest disclosure and a clear redaction...
These 80-Year-Olds Have the Memory of 50-Year-Olds. Scientists Now Know Why
Northwestern Medicine’s 25‑year SuperAging program has identified a cohort of 80‑plus adults whose memory performance matches that of people in their 50s. Researchers found that these “SuperAgers” exhibit unusually thick cortical regions and a higher density of von Economo neurons, which...
AAN 2026: J&J, Kyverna, Capricor and Praxis Showcase Practice-Changing Data
At the 2026 American Academy of Neurology meeting, Johnson & Johnson reported two‑year Phase 3 data showing its FcRn blocker Imaavy sustained symptom improvement and allowed most patients to cut corticosteroid use. Kyverna Therapeutics presented Phase 2 results for its CAR‑T therapy...
DemeRx Reports the US FDA IND Application Acceptance to Advance DMX-1001 for Alcohol Use Disorder
DemeRx announced that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for DMX-1001, an oral formulation of noribogaine, to treat alcohol use disorder (AUD). The company recently completed a multiple‑ascending‑dose (MAD) trial in healthy...
Senior Lucy Letby Hospital Boss Arrested
A senior executive at the Countess of Chester Hospital was arrested on suspicion of perverting the course of justice, part of Cheshire Police's Operation Duet. The operation investigates both corporate manslaughter and gross negligence manslaughter linked to the 2023 convictions of...
UNPACKING THE CHALLENGES FACING SOUTH AFRICA’S HEALTHCARE REFORM
South Africa’s post‑apartheid health system has shifted toward greater inclusivity, but stark gaps between public and private care persist. The National Health Insurance scheme, touted as a path to universal coverage, faces a Constitutional Court decision slated for May 2026, prompting...
Gravity Rail Raises $2.75M From Redesign Health for AI Patient Communication
Gravity Rail, an AI‑driven platform that automates patient calls, texts and follow‑up workflows, announced a $2.75 million seed round led by Redesign Health. The funding will accelerate product development and expand its go‑to‑market team. Gravity Rail’s technology aims to streamline enrollment,...
Infinitus Systems Launches “Studio”: The First No-Code AI Agent Builder Purpose-Built for Healthcare Complexity
Infinitus Systems has launched Studio, a no‑code AI agent builder designed specifically for healthcare. The platform lets operational teams create and deploy agents via a natural‑language interface, cutting deployment time by 90% and boosting accuracy 40% over manual methods. Its...
UFP Technologies: Great Growth At Just An Okay Price
UFP Technologies (UFPT) is delivering strong revenue and profit growth in the MedTech space, fueled by strategic acquisitions and expanding exposure to high‑growth areas such as robotic surgery and infection‑prevention products. The company benefits from a $550 billion MedTech market and...
Algeria Eliminates Trachoma as a Public Health Problem
The World Health Organization has officially validated Algeria’s elimination of trachoma as a public health problem, making it the 10th country in the African Region and the 29th worldwide to achieve this status. Trachoma, the leading infectious cause of blindness,...
Regeneron and Sanofi Report the US FDA Approval of Dupixent (Dupilumab) for Chronic Spontaneous Urticaria (CSU)
Regeneron and Sanofi announced that the U.S. Food and Drug Administration has approved Dupixent (dupilumab) for chronic spontaneous urticaria (CSU) in patients as young as two years old who remain symptomatic despite H1 antihistamines. The decision is based on two...
Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins
Dexcom (DXCM) is positioned to profit from the booming weight‑loss drug market, as GLP‑1 therapies drive both new diabetes diagnoses and higher CGM adoption among patients. The company reports faster CGM usage growth among GLP‑1 users and highlights a still‑under‑penetrated...
How Employers End up Paying for Weight Gain
Employers are rapidly adding GLP‑1 weight‑loss drugs to health plans, but more than half of participants abandon therapy within a year, eroding the expected return on investment. While some firms pair prescriptions with nutrition coaching and behavior‑change programs, only about...
Oura’s Strategic Acquisition of Galen AI and the Future of Personal Medical Sovereignty
On April 17, 2026 Oura Health announced the acquisition of Galen AI, a Stanford‑born startup that unifies fragmented medical records via FHIR. The deal expands Oura’s smart ring from a fitness tracker to a connected health companion that can cross‑reference...
/file/attachments/orphans/Image-1-Bukhosi-Mdletshe_405154.jpg)
SPOTLIGHT: ‘I’m Serving My People’: The Pastor Running a Rural Clinic that Treats More than Illness
Bukhosi Mdletshe, a pastor and operational manager of Ensingweni Clinic in KwaZulu‑Natal’s King Cetshwayo District, oversees a rural health hub serving roughly 12,000 people spread across a 60‑km area. The clinic combines basic medical services with proactive home‑based care, deploying...
Novo Nordisk’s Oral Semaglutide Demonstrates Potential to Be the First Oral GLP-1 RA Therapy for Children and Adolescents with Type...
Novo Nordisk reported positive topline results from the phase 3a PIONEER TEENS trial, the first study of an oral GLP‑1 receptor agonist in children and adolescents with type 2 diabetes. Oral semaglutide lowered HbA1c by 0.83 percentage points versus placebo...
Are You Waiting for Opioid Settlement Money From Purdue, Mallinckrodt or Endo? Get in Touch.
ProPublica and The Philadelphia Inquirer are probing how victims of the U.S. opioid crisis are being compensated under the bankruptcy settlements of Purdue Pharma, Mallinckrodt and Endo. A recent investigation highlights that Purdue’s revised bankruptcy plan trims payouts and omits...
Operational Lessons From Global Nephrology Trials
The article outlines four operational lessons drawn from the surge of global nephrology trials, noting that GlobalData tracks 888 CKD studies with only 56 multinational efforts. It argues that traditional site selection in Europe and the U.S. limits enrollment speed...
Could Anemia Increase the Risk of Developing Dementia?
A Swedish cohort of 2,282 adults aged 60+ was followed for up to 16 years to examine anemia’s link to dementia. Researchers found that baseline anemia raised the risk of developing dementia by 66 % compared with normal hemoglobin levels. The...
WHO Reports Measurable Health Impact in 2025 Amid Transition to New Strategy
The World Health Organization released its 2025 Results Report, the final assessment of its Thirteenth General Programme of Work, showing measurable progress across the Triple Billion targets despite funding cuts. Compared with a 2018 baseline, an extra 567 million people accessed...
FDA Grants Clearance for Philips’ Rembra Scanning Platform
Philips has secured FDA 510(k) clearance for its Rembra platform, encompassing the Rembra CT scanner, Rembra RT and Areta RT radiation‑therapy systems. The CT unit features an 85 cm bore and can handle up to 270 exams per day, targeting high‑throughput...
ModeX Starts Dosing in MDX2003 Trial for B-Cell Lymphoma
ModeX Therapeutics, an OPKO Health subsidiary, has begun dosing the first patients in the MDX‑2003‑101 trial of its tetraspecific T‑cell engager MDX2003 for relapsed or refractory B‑cell lymphoma. The study will evaluate tolerability, pharmacokinetics, safety and immune activity across dose‑escalation...
Epitopea Wins UK Approval for Therapeutic Vaccine Trial
Epitopea secured UK regulator and ethics committee clearance to launch OVACT, a Phase I/Ib first‑in‑human trial of its RNA‑based vaccine CryptiVax‑1001 in advanced high‑grade serous ovarian cancer. The study will evaluate safety, tolerability, immunogenicity and early clinical activity in HRP⁺/BRCA‑wildtype...
New Case Law Could Put Radiologists on Hook for Imaging-Order Appropriateness
A 2025 Ohio appellate decision, Kelley v. Horton, allowed the American College of Radiology’s Appropriateness Criteria to be used in a malpractice trial, marking the first time the guidelines were admitted as evidence. The case involved two MRIs ordered by...
Interventional Radiologists Launch New Chain of Standalone Outpatient IR Centers
Two California interventional radiologists have launched Elmnt IR, a chain of standalone outpatient interventional radiology centers, beginning with a flagship location in Los Angeles. The venture targets high‑impact conditions such as benign prostatic hyperplasia, uterine fibroids, knee osteoarthritis, and select...
AstraZeneca Reports the P-III (I CAN) Trial Data on Ultomiris for IgA Nephropathy
AstraZeneca announced interim Phase III (I CAN) data for Ultomiris in IgA nephropathy, enrolling about 510 high‑risk adults. The trial met its primary endpoint, showing a roughly 30% reduction in 24‑hour proteinuria at 34 weeks, with benefits evident as early as 10...
Voice Therapy App Improving Outcomes for Parkinson’s Patients at University Hospitals of Derby and Burton
University Hospitals of Derby and Burton introduced a voice‑therapy app for Parkinson’s patients, enabling home‑based exercises after an initial in‑person assessment. The pilot saved 14‑17 hours of clinical time each month, equivalent to six extra therapy slots per week, and...
Mainetti Launches MAMI – A Non-Profit Initiative Supporting Premature Infants in Neonatal Intensive Care Units Across Italy
Mainetti Italia and the Cuore di Maglia Association have launched MAMI, a non‑profit initiative that supplies CE‑certified therapeutic fabric gloves to premature infants in neonatal intensive care units (NICUs) across Italy. The gloves, made from fire‑proof fabric and polypropylene granules,...
Trelleborg Costa Rica Site Earns ISO 13485 Certification
Trelleborg Medical Solutions' Costa Rica manufacturing site earned ISO 13485:2016 certification, confirming its quality management for medical devices. The 107,600‑sq‑ft facility, opened in December 2025 in the Evolution Free Zone, is the company’s first Central American plant and supports nearshoring and supply‑chain...
ICR Bolsters Healthcare Unit
ICR announced two senior hires to strengthen its healthcare communications franchise: John Capodanno was named head of U.S. healthcare corporate communications, and Matthew Willey was appointed managing director of the medical‑technology and diagnostics practice. Capodanno brings over 25 years of...
Utepreva Launches Utepreva Endometrial Sampler to Support Early Diagnosis of Endometrial Cancer
Utepreva has introduced the Utepreva Endometrial Sampler, a single‑use device aimed at improving tissue capture for early endometrial cancer diagnosis, slated for market release in October 2026. The sampler integrates a sponge tip, plunger‑driven suction, and a collection chamber to...
Fraunhofer IAP and NMI Achieve Biomimetic Tissue Mechanics
Fraunhofer IAP and NMI have created a patent‑pending biomimetic tissue substitute that combines a polyurethane acrylate base, a 3D‑printed wavy metastructure, and an electrospun collagen surface. The metastructure reproduces the nonlinear stiffness of pericardial tissue, while the collagen layer supports...
ViewsML Closes Funding Round to Accelerate Commercialization of AI-Driven Virtual Biomarker Staining Platform
ViewsML announced an oversubscribed $4.9 million seed round led by Wittington Ventures, with new investors Mayo Clinic and Continuum Health Ventures joining repeat backers. The capital will fast‑track commercialization of its AI‑driven virtual biomarker staining platform, which extracts per‑cell biomarker insights...
Iran War Pushing up Till Price of some Drugs by up to 30%, Pharmacies Warn
The Iran‑U.S. conflict has driven up fuel and air‑freight costs, pushing wholesale drug prices in England up 40‑50%. Community pharmacies now charge 20‑30% more for over‑the‑counter painkillers and hay‑fever tablets, with a 100‑tablet pack of paracetamol rising from £0.41 ($0.52)...
Engineering Insights: Polyimide, PTFE & Reinforced Tubing for Next-Gen Devices
MicroLumen’s white paper spotlights polyimide and PTFE‑polyimide composite tubing as pivotal for next‑generation catheters. The thermoset polyimide delivers unmatched dimensional stability under mechanical and thermal loads, while PTFE adds low‑friction surfaces. Engineers can tailor torque, pushability, and flexibility through braided...
How States Can Solve Mental Health Workforce Shortages
Emergency department visits for suicide attempts more than tripled between 2015 and 2020, highlighting a critical need for robust suicide screening in hospitals. Yet about half of accredited hospitals report staffing shortages that impede consistent, evidence‑based care. Roughly 40% of...
FMRI-Based Mega-Study of Psychedelics Reveals Patterns of Brain Signaling Reorganization
An international consortium analyzed resting‑state fMRI scans from over 250 healthy volunteers who received psilocybin, LSD, DMT, mescaline or ayahuasca, creating the largest pooled dataset of psychedelic brain imaging to date. Using a unified processing pipeline and Bayesian hierarchical modeling,...
State High Court Weighs in on Woman Taken for Organ Donation But Was Still Alive
A Mississippi woman declared brain‑dead was taken to the state organ recovery agency, only to revive with signs of life, prompting lawsuits alleging negligence and unauthorized sedation. The daughter’s bystander claim was dismissed, while the broader question of whether the...
How to Scale a Private Medical or Dental Practice From One to 100 Locations
Paul Vigario, CEO of SurfCT, argues that scaling a private medical or dental practice from one to 100 locations hinges on building a flawless first office rather than perfecting clinical skills or splurging on equipment. He warns that perfectionism and...
Strata 2026 Healthcare Financial Outlook Report: Medicaid Cuts and Labor Costs Top CFO Concerns
Strata Decision Technology’s 2026 Healthcare Financial Outlook finds Medicaid reimbursement cuts and rising labor expenses now dominate CFO agendas, with 66% naming Medicaid cuts as their top concern. While 43% anticipate modest margin growth, 25% expect declines, underscoring a focus...
Muons, Massive Waves and Restored Sight: The Winners at the ‘Oscars of Science’ – Podcast
The Breakthrough Prize, dubbed the "Oscars of science," handed out $3 million awards in physics, mathematics and life sciences at a high‑profile ceremony in Los Angeles. Jean Bennett was among the laureates, receiving the life‑sciences prize for co‑creating the first FDA‑approved gene‑augmented...
InteliCare to Enter New Sector with Warrigal Care Contract for 65 Retirement Villas
InteliCare Holdings signed a three‑year, $200,000 Master Subscription Agreement with Warrigal Care to install its AI‑driven sensor platform in 65 retirement villas, marking the company’s first foray into the retirement‑village market. The deal opens a pathway to expand across Warrigal’s...
Before Vaccines, Diphtheria Used to Kill Hundreds Each Year. Now It’s Back in Australia
Australia is witnessing a resurgence of diphtheria, with the Northern Territory reporting 17 respiratory cases and 60 cutaneous cases in the past year, and Western Australia’s Kimberley region logging 27 cases in the last month. The outbreak extends to Queensland...
New Study Offers Insight Into the Type of AI Radiologists Prefer
Researchers at Moffitt Cancer Center evaluated 200 CT‑scan reports generated by a general‑purpose large language model (LLM) and a domain‑specific AI fine‑tuned on radiology and oncology data. Radiologists consistently preferred the specialized model, citing greater completeness, accuracy and conciseness, and...